And the Executive Chairman and acting CEO of Quanterix, Dr. Martin Madaus, Ph.D, was previously President, CEO and head of North American Operations for Roche Diagnostics Corporation. Prior to this he served as Vice President of Business Development for Roche Molecular Diagnostics. http://www.quanterix.com/company/index.html
Read into that what you will, but apart from anything else I would suggest that Geoff personally would be very keen on seeing the detection rates of prostrate cancer improved, following a discussion I had with him about my own terminally-ill father.
- Forums
- ASX - By Stock
- ADO
- mixngo the disruptive technology
mixngo the disruptive technology, page-3
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.79M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $12.09K | 604.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1032452 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 143537 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1032452 | 0.020 |
16 | 2467401 | 0.019 |
7 | 2493502 | 0.018 |
5 | 1724748 | 0.017 |
2 | 482000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 143537 | 3 |
0.022 | 425988 | 6 |
0.023 | 540459 | 7 |
0.024 | 141966 | 2 |
0.025 | 202146 | 4 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online